Travere Therapeutics Inc (TVTX)

09:33 AM

Does Travere Therapeutics Inc. show high probability of reboundJuly 2025 Short Interest & Low Risk High Win Rate Picks - newser.com

09:33 AM

07:15 AM

Detecting support and resistance levels for Travere Therapeutics Inc.July 2025 Patterns & Reliable Momentum Entry Alerts - newser.com

07:15 AM

07:09 AM

Will Travere Therapeutics Inc. stock gain from strong economyJuly 2025 Momentum & Consistent Profit Alerts - newser.com

07:09 AM

05:03 AM

Results: Travere Therapeutics, Inc. Exceeded Expectations And The Consensus Lifted Next Year's Outlook - Yahoo Finance

05:03 AM

04:03 AM

Real time scanner hits for Travere Therapeutics Inc. explainedWeekly Earnings Recap & AI Driven Stock Price Forecasts - newser.com

04:03 AM

03:38 AM

What recovery options are there for Travere Therapeutics Inc.Take Profit & Weekly Breakout Stock Alerts - newser.com

03:38 AM

03:29 AM

Can Travere Therapeutics Inc. stock hit analyst price targetsJuly 2025 PostEarnings & Safe Entry Trade Reports - newser.com

03:29 AM

03:12 AM

Can Travere Therapeutics Inc. stock outperform in 2025 bull marketPortfolio Update Report & Weekly Breakout Opportunity Watchlist - newser.com

03:12 AM

03:05 AM

Cantor Fitzgerald Issues Negative Estimate for TVTX Earnings - MarketBeat

03:05 AM

02:56 AM

Will Travere Therapeutics Inc. stock outperform international peersEarnings Growth Summary & Weekly Hot Stock Watchlists - newser.com

02:56 AM

02:40 AM

What momentum shifts mean for Travere Therapeutics Inc.July 2025 Summary & Accurate Technical Buy Alerts - newser.com

02:40 AM

01:42 AM

Travere Therapeutics (TVTX) Climbs 25% on Impressive Earnings - Insider Monkey

01:42 AM

Nov 02, 2025

How moving averages guide Travere Therapeutics Inc. tradingMarket Performance Summary & Precise Swing Trade Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Travere Therapeutics (TVTX) Hits Fresh High on Impressive Earnings, Bullish Outlook - MSN

Nov 02, 2025

Nov 02, 2025

Can Travere Therapeutics Inc. stock deliver strong Q4 earningsWeekly Trade Summary & Growth-Oriented Investment Plans - newser.com

Nov 02, 2025

Nov 02, 2025

What indicators show strength in Travere Therapeutics Inc.July 2025 Institutional & Long-Term Investment Growth Plans - newser.com

Nov 02, 2025

Nov 02, 2025

Pattern recognition hints at Travere Therapeutics Inc. upside2025 Market Trends & Community Consensus Stock Picks - newser.com

Nov 02, 2025

Nov 02, 2025

When is the best time to exit Travere Therapeutics Inc.CEO Change & Free High Return Stock Watch Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Travere Therapeutics Stock (TVTX) Opinions on Q3 Earnings Surge - Quiver Quantitative

Nov 02, 2025

Nov 02, 2025

How geopolitical tensions affect Travere Therapeutics Inc. stockJuly 2025 Weekly Recap & Technical Buy Zone Confirmations - newser.com

Nov 02, 2025

Nov 02, 2025

Jennison Associates LLC Sells 80,602 Shares of Travere Therapeutics, Inc. $TVTX - MarketBeat

Nov 02, 2025

Nov 02, 2025

10 Stocks With Easy 20-40% Gains - Insider Monkey

Nov 02, 2025

Nov 02, 2025

Travere Therapeutics, Inc. (NASDAQ:TVTX) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 02, 2025

Nov 01, 2025

TD Cowen Forecasts Strong Price Appreciation for Travere Therapeutics (NASDAQ:TVTX) Stock - MarketBeat

Nov 01, 2025

Nov 01, 2025

Why Travere Therapeutics Inc. stock could outperform in 2025Market Trend Report & Reliable Price Breakout Alerts - newser.com

Nov 01, 2025

Nov 01, 2025

Travere Therapeutics (NASDAQ:TVTX) Stock Price Expected to Rise, Citigroup Analyst Says - MarketBeat

Nov 01, 2025

Nov 01, 2025

A Look at Travere Therapeutics's Valuation Following Strong Q3 Profit and FILSPARI Momentum - Yahoo Finance

Nov 01, 2025

Nov 01, 2025

Travere Therapeutics (NASDAQ:TVTX) Reaches New 1-Year High Following Earnings Beat - MarketBeat

Nov 01, 2025

Nov 01, 2025

Travere Therapeutics (TVTX) Is Up 25.3% After FILSPARI Drives Q3 Profit Turnaround and Global Milestone - Yahoo Finance

Nov 01, 2025

Nov 01, 2025

Travere Therapeutics stock hits 52-week high at 33.66 USD By Investing.com - Investing.com Australia

Nov 01, 2025

Oct 31, 2025

Travere Therapeutics (TVTX): Unprofitable But Forecast 67% Annual Earnings Growth Challenges Bearish Narratives - Yahoo Finance

Oct 31, 2025

Oct 31, 2025

TD Cowen Raises Price Target for Travere Therapeutics (TVTX) to $40 | TVTX Stock News - GuruFocus

Oct 31, 2025

Oct 31, 2025

Travere Therapeutics’ Strong Quarter and Future Prospects - TipRanks

Oct 31, 2025

Oct 31, 2025

Travere Therapeutics Delivers Growth As FILSPARI Drives Profits - Finimize

Oct 31, 2025

Oct 31, 2025

Eric Dube Sells 92,872 Shares of Travere Therapeutics (NASDAQ:TVTX) Stock - MarketBeat

Oct 31, 2025

Oct 31, 2025

Travere Therapeutics (NASDAQ:TVTX) Insider Sells $79,860.00 in Stock - MarketBeat

Oct 31, 2025

Oct 31, 2025

Insider Selling: Travere Therapeutics (NASDAQ:TVTX) CEO Sells 27,128 Shares of Stock - MarketBeat

Oct 31, 2025

Oct 31, 2025

Travere signals readiness for rapid FILSPARI launch in FSGS as Q3 2025 revenue hits $164.9M - MSN

Oct 31, 2025

Oct 31, 2025

Travere Therapeutics (NASDAQ:TVTX) Releases Quarterly Earnings Results, Beats Estimates By $0.59 EPS - MarketBeat

Oct 31, 2025

Oct 31, 2025

Travere Therapeutics stock hits 52-week high at 33.66 USD - Investing.com

Oct 31, 2025

Oct 31, 2025

Travere Therapeutics (TVTX) Sees Increased Price Target and Posi - GuruFocus

Oct 31, 2025

Oct 31, 2025

Top 2% Biotech Screams Up A Beat On Its Linchpin Drug - Investor's Business Daily

Oct 31, 2025

Oct 31, 2025

Emerald Mutual Fund Advisers Trust Has $16.89 Million Stock Holdings in Travere Therapeutics, Inc. $TVTX - MarketBeat

Oct 31, 2025

Oct 31, 2025

Backtesting results for Travere Therapeutics Inc. trading strategiesMarket Movement Recap & Safe Entry Momentum Tips - newser.com

Oct 31, 2025

Oct 31, 2025

Travere therapeutics CEO Dube sells $3.6m in TVTX stock By Investing.com - Investing.com Canada

Oct 31, 2025